Metraipolis › archive › dc_ee8a657e5187

Efficacy and Safety of Once-Weekly Semaglutide Versus Basal Insulin and Other GLP-1 Receptor Agonists in Adults With Type 2 Diabetes Uncontrolled on Oral… — Europe PMC PMID:42495484

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42495484
DOI
10.7759/cureus.111363
License (as archived)
solo-consultazione
Archived
2026-10-19T06:07:43.469Z
SHA-256 of the archived text
5668ed4888d96f0f1fe251cef9014ae0f396893a332f12e53b37276dbe066d65
Stable URL of this page
https://metraipolis.com/documento/dc_ee8a657e5187

How to cite

Efficacy and Safety of Once-Weekly Semaglutide Versus Basal Insulin and Other GLP-1 Receptor Agonists in Adults With Type 2 Diabetes Uncontrolled on Oral… — Europe PMC PMID:42495484 — Europe PMC (en), https://europepmc.org/article/MED/42495484 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee8a657e5187 (Metraipolis archive dc_ee8a657e5187, sha256 5668ed4888d96f0f1fe251cef9014ae0f396893a332f12e53b37276dbe066d65)
BibTeX
@misc{dcee8a657e5187,
  title = {Efficacy and Safety of Once-Weekly Semaglutide Versus Basal Insulin and Other GLP-1 Receptor Agonists in Adults With Type 2 Diabetes Uncontrolled on Oral… — Europe PMC PMID:42495484},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42495484},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee8a657e5187; sha256 5668ed4888d96f0f1fe251cef9014ae0f396893a332f12e53b37276dbe066d65},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42495484. Agents can read the archived copy with the MCP tool read_document.